← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Inflammatix, Inc.
Sunnyvale, CA
$2,252,971
Total funding
3
Grants
Funding over time
peak $1M · FY2021–23$2M$1.5M$1M$500K$0
'21
'22
'23
Funding mix
By agency
NIH$2,252,971 · 3
By mechanism
R44$1,701,838 · 1
R43$551,133 · 2
Investigators at Inflammatix, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Validation and early development of a blood-based rapid diagnostic test for sepsis endotypes$1,017,950
R44 · FY2022 · GM
Validation and early development of a blood-based rapid diagnostic test for sepsis endotypes$683,888
R44 · FY2021 · GM
Development of a multi-RNA signature in blood towards a rapid diagnostic test to robustly distinguish patients with acute myocardial infarction$299,762
R43 · FY2023 · HL
DEVELOPMENT OF BASELINE GENE EXPRESSION-BASED RESPONSE PREDICTOR FOR ANTI-TNFA THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES$251,371
R43 · FY2021 · DK